当前位置:首页 - 行情中心 - 悦康药业(688658) - 财务分析 - 现金流量表

悦康药业

(688658)

  

流通市值:93.11亿  总市值:93.11亿
流通股本:4.50亿   总股本:4.50亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金2,002,252,209.141,385,776,592.31666,594,870.054,259,122,192.36
  收到的税费返还6,959,117.175,493,803.36-25,751,610.02
  收到其他与经营活动有关的现金90,467,494.8582,900,935.435,030,867.677,170,649.02
  经营活动现金流入小计2,099,678,821.161,474,171,331.07701,625,737.654,362,044,451.4
  购买商品、接受劳务支付的现金571,785,809.04433,501,407.03221,922,347.561,221,417,656.91
  支付给职工以及为职工支付的现金328,971,560.91225,969,206.86116,478,783.16455,922,125.22
  支付的各项税费150,691,224.29101,684,294.7641,483,283.07393,256,127.88
  支付其他与经营活动有关的现金879,895,937.34720,238,872.42240,699,690.671,853,207,888.9
  经营活动现金流出小计1,931,344,531.581,481,393,781.07620,584,104.463,923,803,798.91
  经营活动产生的现金流量净额168,334,289.58-7,222,45081,041,633.19438,240,652.49
二、投资活动产生的现金流量:
  收回投资收到的现金310,000,000190,000,00060,000,000-
  取得投资收益收到的现金2,153,787.031,658,444.41865,853.74222,284.82
  处置固定资产、无形资产和其他长期资产收回的现金净额107,623.28848.5848.5626,753.04
  收到的其他与投资活动有关的现金10,072,191.7872,191.785,072,191.78-
  投资活动现金流入小计322,333,602.09191,731,484.6965,938,894.02849,037.86
  购建固定资产、无形资产和其他长期资产支付的现金116,921,992.4184,903,020.9357,707,427.51358,601,267.73
  投资支付的现金607,000,000360,000,000-175,000,000
  取得子公司及其他营业单位支付的现金---3,006,500
  支付其他与投资活动有关的现金--10,000,00010,000,000
  投资活动现金流出小计723,921,992.41444,903,020.9367,707,427.51546,607,767.73
  投资活动产生的现金流量净额-401,588,390.32-253,171,536.24-1,768,533.49-545,758,729.87
三、筹资活动产生的现金流量:
  吸收投资收到的现金100,000---
  取得借款收到的现金128,588,063.9128,588,063.975,588,063.9649,010,636.01
  筹资活动现金流入小计128,688,063.9128,588,063.975,588,063.9649,010,636.01
  偿还债务支付的现金64,454,741.0243,262,041.025,320,000510,440,317.6
  分配股利、利润或偿付利息支付的现金14,854,094.619,786,823.954,706,325.39111,248,556.6
  支付其他与筹资活动有关的现金72,695,116.5471,535,122.541,831,185.9255,781,586.3
  筹资活动现金流出小计152,003,952.17124,583,987.5111,857,511.31677,470,460.5
  筹资活动产生的现金流量净额-23,315,888.274,004,076.3963,730,552.59-28,459,824.49
四、汇率变动对现金及现金等价物的影响169,760.33107,617.2344,062.23263,852.38
五、现金及现金等价物净增加额-256,400,228.68-256,282,292.62143,047,714.52-135,714,049.49
  加:期初现金及现金等价物余额1,237,819,140.81,237,819,140.81,237,811,661.251,373,533,190.29
  期末现金及现金等价物余额981,418,912.12981,536,848.181,380,859,375.771,237,819,140.8
补充资料:
  净利润--102,180,151.14-121,246,883.89
  资产减值准备-18,583,861.35-100,545,979.23
  固定资产和投资性房地产折旧-88,571,446.89-175,482,812.96
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-88,571,446.89-175,482,812.96
  无形资产摊销-13,579,767.71-23,957,891.98
  长期待摊费用摊销-2,315,152.5-4,169,393.21
  处置固定资产、无形资产和其他长期资产的损失---383,536.49
  固定资产报废损失-49,686.11-1,918,171.53
  公允价值变动损失----2,344,894.08
  财务费用-11,047,688.87-22,441,984.99
  投资损失--1,385,511.85--477,284.82
  递延所得税--1,855,297.92--9,928,933.09
  其中:递延所得税资产减少--1,855,297.92--9,928,933.09
  存货的减少-159,885,223.75--59,153,628.01
  经营性应收项目的减少-134,209,866.78-276,645,562.46
  经营性应付项目的增加--335,048,781.15--218,898,634.38
  现金的期末余额-981,536,848.18-1,237,819,140.8
  减:现金的期初余额-1,237,819,140.8-1,373,533,190.29
  现金及现金等价物的净增加额--256,282,292.62--135,714,049.49
公告日期2025-10-302025-08-292025-04-292025-03-15
审计意见(境内)标准无保留意见
TOP↑